No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ALKS Alkermes
- 23.370
- -0.200-0.85%
Close Jul 15 16:00 ET
- 23.370
- 0.0000.00%
Post 18:06 ET
3.95BMarket Cap9.13P/E (TTM)
23.740High23.120Low1.74MVolume23.600Open23.570Pre Close40.61MTurnover1.08%Turnover Ratio11.13P/E (Static)169.22MShares32.88052wk High3.15P/B3.76BFloat Cap22.01052wk Low--Dividend TTM160.81MShs Float98.500Historical High--Div YieldTTM2.63%Amplitude3.550Historical Low23.328Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
6 Analysts Assess Alkermes: What You Need To Know
Alkermes (NASDAQ:ALKS) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The table below summarizes their recent ratings, showcasing
Express News | JP Morgan Maintains Neutral on Alkermes, Lowers Price Target to $31
J.P. Morgan Maintains Alkermes(ALKS.US) With Hold Rating, Cuts Target Price to $31
J.P. Morgan analyst Jessica Fye maintains $Alkermes(ALKS.US)$ with a hold rating, and adjusts the target price from $32 to $31.According to TipRanks data, the analyst has a success rate of 55.1% and
Express News | Alkermes PLC : JP Morgan Cuts Target Price to $31 From $32
Express News | Alkermes PLC : Leerink Partners Cuts Target Price to $28 From $30
Piper Sandler Maintains Alkermes(ALKS.US) With Buy Rating, Maintains Target Price $39
Piper Sandler analyst David Amsellem maintains $Alkermes(ALKS.US)$ with a buy rating, and maintains the target price at $39.According to TipRanks data, the analyst has a success rate of 41.2% and a to
Comments
Nancy S. Lurker's appointment to Alkermes' Board is viewed positively, bringing deep industry experience and commercial expertise. Her broad skills are expected to drive growth of existing products, portfolio expansion, and new product launches.
Press Release: Alkermes Announces Appointment of Nancy S. Lurker to Board of DirectorsAlkermes' surplus of cash over debt and its ability to convert EBIT to free cash flow indicate a conservative balance sheet and low risk in its debt management.
Although Alkermes' share price has recently dipped, its long-term business trends are positive. Insider purchases, often seen as a good omen by investors, add further optimism.
$Alkermes(ALKS.US$ huge call options in dec, unusual. buyout for JPM healthcare conference next week?
Gainers:
• $AngioDynamics(ANGO.US$ +13.5%, $Skillsoft(SKIL.US$ +3.26%, $Sprinklr(CXM.US$ +8.96%, $Cazoo(CZOO.US$ +11.1%, $Apogee Enterprises(APOG.US$ +3.3%, $Levi Strauss & Co.(LEVI.US$ +1.7%, $Constellation Brands(STZ.US$ + 0.8%
• $Momentus(MNTS.US$ +36.9% (signed multiple launch agreements with Space Exploration Technologies Corp)
• $HP Inc(HPQ.US$ +10.1% (Berkshire Hathaway's Warren Buffett disclosed the purchase of mln sh...
• $AngioDynamics(ANGO.US$ +13.5%, $Skillsoft(SKIL.US$ +3.26%, $Sprinklr(CXM.US$ +8.96%, $Cazoo(CZOO.US$ +11.1%, $Apogee Enterprises(APOG.US$ +3.3%, $Levi Strauss & Co.(LEVI.US$ +1.7%, $Constellation Brands(STZ.US$ + 0.8%
• $Momentus(MNTS.US$ +36.9% (signed multiple launch agreements with Space Exploration Technologies Corp)
• $HP Inc(HPQ.US$ +10.1% (Berkshire Hathaway's Warren Buffett disclosed the purchase of mln sh...
15
3
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg